Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies. [electronic resource]
Producer: 20130129Description: e43468 p. digitalISSN:- 1932-6203
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Alkylating -- pharmacology
- Apoptosis -- drug effects
- Carmustine -- pharmacology
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cellular Senescence -- drug effects
- Dacarbazine -- analogs & derivatives
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Gene Knockdown Techniques
- Glioblastoma -- drug therapy
- Guanine -- analogs & derivatives
- Humans
- Lysine -- analogs & derivatives
- Male
- Mixed Function Oxygenases -- genetics
- Molecular Targeted Therapy
- Neoplasm Grading
- Oxidoreductases Acting on CH-NH Group Donors -- antagonists & inhibitors
- Peptide Initiation Factors -- deficiency
- RNA-Binding Proteins -- genetics
- Temozolomide
- Eukaryotic Translation Initiation Factor 5A
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.